 | Rimonabant | IC50 | 6.0 [1] |
| Rimonabant | Ki | 0.43 [1], 1.6 [2], 5.4 [3] |
 | Win 55212-2 | IC50 | 16.0 [1], 17.0 [2] |
| Win 55212-2 | Ki | 3802.0 [1] |
 | 5-(1,1-Dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol | IC50 | 0.13 [1] |
 | Anandamide | Ki | 89.0 [1] |
 | Taranabant | IC50 | 0.3 [1] |
| Taranabant | Ki | 0.3 [1] |
 | Dronabinol | IC50 | 2.8 [1] |
 | (6AR,10AR)-3-(1,1-Dimethylbutyl)-6A,7,10,10A-tetrahydro-6,6,9-trimethyl-6H-dibenzo[B,D]pyran | IC50 | 10000.0 [1] |
 | Ibipinabant | IC50 | 17.0 [1], 19.95 [2] |
 | CID 3081355 | IC50 | 794.33 [1] |
 | (2-Iodo-5-nitrophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone | IC50 | 280.0 [1] |
 | (Inverted exclamation markA)-SLV319 | IC50 | 1.91 [1], 22.0 [2], 139.0 [3] |
| (Inverted exclamation markA)-SLV319 | Ki | 25.0 [1], 25.2 [2] |
 | (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone | Ki | 383.0 [1], 1202.26 [2], 1204.0 [3] |
 | (2,3-Dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone | Ki | 1917.0 [1], 2000.0 [2], 4800.0 [3] |
 | 12-Chloro-3-(2,4-dichlorophenyl)-N-piperidin-1-yl-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaene-5-carboxamide | Ki | 0.0 [1], 5.55 [2], 18.4 [3], 126.0 [4] |
 | (1-(2-Morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | IC50 | 330.0 [1] |
| (1-(2-Morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | Ki | 845.0 [1], 954.99 [2] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 0.77 [1], 0.83 [2] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 12.3 [1] |
 | 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone | IC50 | 15.0 [1], 1580.0 [2] |
| 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone | Ki | 35.0 [1] |
 | 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-5,6-dihydropyrazolo[3,4-f][1,4]oxazepin-8-one | Ki | 0.82 [1], 1.0 [2] |
 | (3-Benzyl-3-methyl-2,3-dihydrobenzofuran-6-yl)(piperidin-1-yl)methanone | Ki | 10000.0 [1] |
 | Naphthyridinone | IC50 | 7.5 [1] |
 | 6-Methoxy-5-(2-morpholin-4-ylethyl)-2-[(1S,2S,4R)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrido[4,3-b]indol-1-one | Ki | 16.0 [1], 16.4 [2] |
 | 5-(4-Chlorophenyl)-N-cyclohexyl-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide | Ki | 1.8 [1], 3.7 [2], 5.0 [3], 42.0 [4] |
 | N-Cyclohexyl-4-[(2,4-dichlorophenyl)(p-tolyl)methyl]piperazine-1-carboxamide | IC50 | 2.7 [1] |
| N-Cyclohexyl-4-[(2,4-dichlorophenyl)(p-tolyl)methyl]piperazine-1-carboxamide | Ki | 0.15 [1] |
 | 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-5-methyl-6-(2,2,2-trifluoroethyl)pyrazolo[4,3-d]pyrimidin-7-one | Ki | 0.6 [1], 1.0 [2] |
 | 5-(4-Chlorophenyl)-N-cyclohexyl-1-(2,4-dichlorophenyl)-N,4-dimethylpyrazole-3-carboxamide | Ki | 30.0 [1], 54.0 [2], 100.0 [3], 107.0 [4] |
 | 1-[(4-Fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | Ki | 200.0 [1], 300.0 [2] |
 | 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-N-[[4-(methanesulfonamidomethyl)cyclohexyl]methyl]-4-methylpyrazole-3-carboxamide | Ki | 8.0 [1], 11.0 [2], 36.0 [3], 55.0 [4] |
 | 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-[[4-[(sulfamoylamino)methyl]cyclohexyl]methyl]pyrazole-3-carboxamide | Ki | 15.0 [1], 21.0 [2], 107.0 [3], 135.0 [4] |
 | (2S)-2-Cyclohexyl-2-[[1-(cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]acetic acid | IC50 | 2000.0 [1] |
| (2S)-2-Cyclohexyl-2-[[1-(cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]acetic acid | Ki | 3062.0 [1] |
 | alpha-Methyl anandamide | Ki | 53.0 [1], 137.0 [2] |
 | 2-Arachidonoylglycerol | Ki | 470.0 [1], 480.0 [2], 1000.0 [3] |
 | Nabilone | Ki | 2.19 [1], 5.1 [2] |
 | [(1R,4S,5R)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | Ki | 10000.0 [1] |
 | Otenabant | Ki | 0.12 [1], 0.7 [2] |
 | Psncbam 1 | IC50 | 33.0 [1], 50.0 [2], 230.0 [3] |
 | 1-(2,4-Dichlorophenyl)-6-methyl-N-(1-piperidinyl)-4H-indeno[1,2-c]pyrazole-3-carboxamide | Ki | 363.0 [1] |
 | Unii-U90K6D923K | Ki | 0.32 [1] |
 | 1-[[6-Ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | IC50 | 2000.0 [1] |
| 1-[[6-Ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | Ki | 4067.0 [1], 4600.0 [2] |
 | CID 5311216 | Ki | 4888.0 [1], 20000.0 [2] |
 | [4-(3,5-Dichlorophenyl)-3,5-dihydroxyphenyl]-phenylmethanone | Ki | 27.0 [1], 4778.0 [2] |
 | (6Ar,10aR)-3-(1-hexylcyclopropyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 0.44 [1], 1.0 [2] |
 | (6Ar,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene | Ki | 1043.0 [1], 15850.0 [2] |
 | (6Ar,10aR)-3-(2-hexyl-1,3-dioxolan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 0.5 [1], 0.52 [2] |
 | 1-[(6Ar,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-3-yl]cyclohexane-1-carbonitrile | Ki | 8.3 [1], 8.32 [2] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-naphthalen-1-yl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 11.7 [1], 11.75 [2] |
 | N-(Adamant-1-yl)-6-isopropyl-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide | Ki | 1220.0 [1] |
 | (6Ar,10aR)-3-(2,2-dichloro-1-hexylcyclopropyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 1.26 [1], 1.8 [2] |
 | 2-[[1-(Cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]-2-methylpropanoic acid | Ki | 1351.0 [1], 1354.0 [2] |
 | N-(Piperidin-1-yl)-5,6-dip-tolylpyrazine-2-carboxamide | IC50 | 6.0 [1], 12.02 [2] |
| N-(Piperidin-1-yl)-5,6-dip-tolylpyrazine-2-carboxamide | Ki | 53.0 [1] |
 | 5-(4-Chlorophenyl)-N'-methyl-4-phenyl-N-piperidin-1-ylsulfonyl-3,4-dihydropyrazole-2-carboximidamide | Ki | 152.0 [1] |
 | 3-(2-Morpholinoethyl)-5,5-di(4-bromophenyl)imidazolidine-2,4-dione | Ki | 70.3 [1] |
 | N-[(2S,3S)-4-(4-Chlorophenyl)-3-phenylbutan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxypropanamide | IC50 | 0.5 [1], 0.54 [2] |
 | 5-(4-Chlorophenyl)-N-(diethylsulfamoyl)-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide | Ki | 30.0 [1] |
 | N-Cyclohexyl-1-(3,4-dichlorophenyl)-4-methyl-5-pyrrol-1-ylpyrazole-3-carboxamide | IC50 | 10.0 [1] |
| N-Cyclohexyl-1-(3,4-dichlorophenyl)-4-methyl-5-pyrrol-1-ylpyrazole-3-carboxamide | Ki | 5.6 [1] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-(2-thiophen-2-ylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 1.08 [1], 12.3 [2] |
 | 8-(2-Chlorophenyl)-9-(4-chlorophenyl)-6-(4-methylpiperazin-1-yl)-9H-purine | Ki | 1.6 [1], 2.8 [2], 3.0 [3] |
 | 2,2,3,3-Tetramethyl-N-(4-methyl-3-(morpholinosulfonyl)phenyl)cyclopropanecarboxamide | Ki | 3400.0 [1] |
 | 4-Methyl-3-(morpholinosulfonyl)-N-(2,2,4,4-tetramethylpentan-3-yl)benzamide | Ki | 310.0 [1] |
 | N-(1-Adamantyl)-6-(furan-2-yl)-4-oxo-1-pentylquinoline-3-carboxamide | Ki | 10000.0 [1] |
 | N-(3-Hydroxy-propyl) arachidonoyl amine | Ki | 13.0 [1], 189.0 [2], 364.0 [3] |
 | alpha,alpha-Dimethyl anandamide | Ki | 41.0 [1], 47.0 [2] |
 | 2-(Benzyloxy)-6-(4-chlorophenyl)-5-phenylnicotinonitrile | IC50 | 67.0 [1], 2800.0 [2], 2818.38 [3] |
 | (Z)-Methyl 2-(2-isopropylphenylimino)-5,5-dimethyl-1,3-thiazinane-3-carbodithioate | IC50 | 5000.0 [1] |
| (Z)-Methyl 2-(2-isopropylphenylimino)-5,5-dimethyl-1,3-thiazinane-3-carbodithioate | Ki | 5000.0 [1] |
 | N-[(1S,2S)-3-(4-Chlorophenyl)-1-methyl-2-phenylpropyl]-2-(phenyloxy)-2-methylpropanamide | IC50 | 2.0 [1], 2.03 [2] |
 | 4-((4-Chlorophenyl)(2,4-dichlorophenyl)methyl)-N-cyclohexylpiperazine-1-carboxamide | IC50 | 19.0 [1], 367.0 [2] |
| 4-((4-Chlorophenyl)(2,4-dichlorophenyl)methyl)-N-cyclohexylpiperazine-1-carboxamide | Ki | 0.23 [1] |
 | 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-pyridin-4-ylpyrazole-3-carboxamide | Ki | 13.0 [1], 56.0 [2], 85.0 [3] |
 | 5-(4-Chlorophenyl)-3-[(E)-2-cyclohexylethenyl]-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole | Ki | 31.3 [1], 60.0 [2], 85.0 [3] |
 | 1-(2-Chlorophenyl)-5-(4-chlorophenyl)-4-(cyanomethyl)-N-piperidin-1-ylpyrazole-3-carboxamide | IC50 | 1.8 [1], 7.5 [2] |
 | (2S)-N-[6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydropyrano[2,3-b]pyridin-4-yl]-2-hydroxypropanamide | IC50 | 3.0 [1], 4.8 [2], 78.0 [3] |
 | 1-[5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carbonyl]-4-phenylpiperidine-4-carboxamide | Ki | 0.4 [1], 3.4 [2], 3.44 [3] |
 | 6-Bromo-1-[(4-fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | Ki | 96.1 [1], 121.0 [2], 166.0 [3] |
 | 1-[(4-Fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-6-thiophen-2-yl-1,8-naphthyridine-3-carboxamide | Ki | 430.0 [1], 472.0 [2], 3280.0 [3] |
 | 1-[(4-Fluorophenyl)methyl]-6-(furan-2-yl)-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | Ki | 3444.0 [1], 4056.0 [2], 10000.0 [3] |
 | 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-[(E)-piperidinoiminomethyl]-1H-pyrazole | Ki | 17.0 [1], 19.0 [2], 57.0 [3] |
Calculator
